1. Home
  2. OWLS vs LRMR Comparison

OWLS vs LRMR Comparison

Compare OWLS & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OBOOK Holdings Inc.

OWLS

OBOOK Holdings Inc.

HOLD

Current Price

$5.37

Market Cap

481.4M

Sector

Technology

ML Signal

HOLD

Logo Larimar Therapeutics Inc.

LRMR

Larimar Therapeutics Inc.

HOLD

Current Price

$3.75

Market Cap

455.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OWLS
LRMR
Founded
2010
N/A
Country
Taiwan
United States
Employees
75
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
481.4M
455.8M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
OWLS
LRMR
Price
$5.37
$3.75
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
6
Target Price
$11.00
$16.50
AVG Volume (30 Days)
19.6K
1.8M
Earning Date
04-29-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$6.57
N/A
Revenue Next Year
$375.69
$1,816.14
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.10
$2.72
52 Week High
$29.00
$6.42

Technical Indicators

Market Signals
Indicator
OWLS
LRMR
Relative Strength Index (RSI) 33.02 46.80
Support Level $5.24 $3.01
Resistance Level $6.14 $3.77
Average True Range (ATR) 0.15 0.26
MACD -0.02 -0.01
Stochastic Oscillator 34.85 12.10

Price Performance

Historical Comparison
OWLS
LRMR

About OWLS OBOOK Holdings Inc.

OBOOK Holdings Inc operate as a blockchain-powered technology company. It provides solutions across three main business segments: payments, hospitality, and e-commerce, serving businesses and individuals whose commercial activities involve cross-border transactions. The company has five reportable segments: Payment service provides payment solutions to customers, including payment gateway services and payout services; Hospitality-related software services provide the subscription to the OwlNest PMS and the add-on room fee collection services offered to the clients using OwlNest; Hospitality-related platform services that provide an OTA platform and offline platform services offering accommodation services; The E-commerce platform engages in selling products online; and Other services.

About LRMR Larimar Therapeutics Inc.

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.

Share on Social Networks: